Cargando…

Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients

Since the coronavirus disease 2019 (COVID-19) began to spread, it remains pandemic worldwide. The European Medicines Agency's human medicines committee and Food and Drug Administration have only granted a conditional marketing authorization for remdesivir to treat COVID-19. It is essential to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Zhanjun, Wu, Peipei, Qian, Qianqian, Zhou, Li, Du, Dandan, Ding, Mengxuan, Peng, Tao, Fang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772051/ https://www.ncbi.nlm.nih.gov/pubmed/37521156 http://dx.doi.org/10.1097/ID9.0000000000000033

Ejemplares similares

Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020)

The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Shi, Ming, et al.
Publicado: (2021)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
por: Piyush, Ravikant, et al.
Publicado: (2020)

Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
por: Ouyang, Jing, et al.
Publicado: (2020)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan
por: Hassan, Mozan Osman, et al.
Publicado: (2020)

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
por: Salazar, Eric, et al.
Publicado: (2020)

Corticosteroids: A Controversial Therapy for Coronavirus Disease 2019
por: She, Jun, et al.
Publicado: (2020)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles
por: Im, Jae Hyoung, et al.
Publicado: (2020)

Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019
por: Hartog, Nicholas, et al.
Publicado: (2021)

Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19)
por: Alghamdi, Ahmed N., et al.
Publicado: (2020)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review
por: Grisolia, Gianpaolo, et al.
Publicado: (2020)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates
por: Verma, Henu Kumar, et al.
Publicado: (2020)

Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism
por: Li, Pei Ye, et al.
Publicado: (2023)

Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer
por: Bloch, Evan M, et al.
Publicado: (2021)

Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report
por: Omrani, Ali S., et al.
Publicado: (2020)

Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020)

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
por: Browning, Sabrina L., et al.
Publicado: (2020)

Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
por: Esmaeili, Behnaz, et al.
Publicado: (2021)

Successful Convalescent Plasma Therapy in a Child With Severe Coronavirus Disease
por: Das, Sudipta Sekhar, et al.
Publicado: (2020)

Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report
por: Wang, Min, et al.
Publicado: (2020)

Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
por: Rahardjo, Theresia Monica, et al.
Publicado: (2021)

Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma
por: Kong, Yujie, et al.
Publicado: (2020)

Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients
por: Gharbharan, Arvind, et al.
Publicado: (2021)

Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports
por: Thabrani, Achmad, et al.
Publicado: (2021)

Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
por: Salazar, Eric, et al.
Publicado: (2020)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Coronavirus disease 2019 and its controversial results during pregnancy
por: Volpato, Fernanda, et al.
Publicado: (2021)

Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
por: Huang, Li, et al.
Publicado: (2021)

Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019
por: Bainbridge, Emma D, et al.
Publicado: (2021)

Effect of convalescent plasma transfusion on outcomes of coronavirus disease 2019: a meta-analysis with trial sequential analysis
por: Hakim, Sameh M., et al.
Publicado: (2023)

Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
por: Baksh, Sheriza N, et al.
Publicado: (2023)

Coronavirus controversy
por: Hofer, Ursula
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8khbvph1lqk2b7qdn4agk88eqg